FMP
BiondVax Pharmaceuticals Ltd.
BVXV
NASDAQ
Inactive Equity
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
1.36 USD
0.01 (0.735%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Amir Reichman M.B.A., M.Sc.
sector
Healthcare
industry
Biotechnology
website
https://www.biondvax.comexchange
NASDAQ
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
CIK
0001611747
ISIN
US09073Q1058
CUSIP
09073Q105
Address
Jerusalem BioPark Building
Phone
972 8 930 2529
Country
IL
Employee
33
IPO Date
May 12, 2015
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
BVXV Financial Summary
CIK
0001611747
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
09073Q105
ISIN
US09073Q1058
Country
IL
Price
1.36
Beta
2.37
Volume Avg.
38.94k
Market Cap
4.97M
Shares
-
52-Week
0.63-11.49
DCF
1.57
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.58
P/B
-
Website
https://www.biondvax.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BVXV News
It looks like there's no news available.
